Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health state

Journal of Cystic Fibrosis

Volumn 11, Issue 3, 2012, Pages 216-222

  Quon, Bradley S ^a,b   Patrick, Donald L ^c   Edwards, Todd C ^c   Aitken, Moira L ^a   Gibson, Ronald L ^d   Genatossio, Alan ^d   McNamara, Sharon ^d   Goss, Christopher H ^a,d  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; MALE; OUTCOME ASSESSMENT; PEDOMETER; PHYSICAL ACTIVITY; SELF REPORT; SYMPTOM;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; EQUIPMENT DESIGN; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; MALE; MONITORING, PHYSIOLOGIC; MOTOR ACTIVITY; WALKING; YOUNG ADULT;

EID: 84860607946     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.12.002     Document Type: Article

References (35)

1. Cystic Fibrosis Foundation Dare to dream. Drug Development Pipeline 2009.
2. Mayer-Hamblett N., Ramsey B.W., Kronmal R.A. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thorac Soc 2007, 4:370-377.
3. Food and Drug Administration Guidance for industry patient reported outcome measures: use in medical product development to support labeling claims 2006, Department of Health and Human Services, Rockville, MD.
4. Hay J.A., Cairney J. Development of the habitual activity estimation scale for clinical research: a systematic approach. Pediatr Exerc Sci 2006, 18:193-202.
5. Shephard R.J. Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 2003, 37:197-206. [discussion].
6. Bassett D.R., Cureton A.L., Ainsworth B.E. Measurement of walking distance - questionnaire versus pedometer. Med Sci Sports Exerc 2000, 35:1018-1023.
7. Tudor-Locke C., McClain J.J., Hart T.L., Sisson S.B., Washington T.L. Expected values for pedometer-determined physical activity in youth. Res Q Exerc Sport 2009, 80:164-174.
8. Bravata D.M., Smith-Spangler C., Sundaram V., Gienger A.L., Lin N., Lewis R., et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007, 298:2296-2304.
9. Nixon P.A., Orenstein D.M., Kelsey S.F., Doershuk C.F. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992, 327:1785-1788.
10. Wells G.D., Wilkes D.L., Schneiderman-Walker J., Elmi M., Tullis E., Lands L.C., et al. Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol 2008, 43:345-353.
11. Dwyer T.J., Alison J.A., McKeough Z.J., Elkins M.R., Bye P.T. Evaluation of the SenseWear activity monitor during exercise in cystic fibrosis and in health. Respir Med 2009, 103:1511-1517.
12. Selvadurai H.C., Blimkie C.J., Cooper P.J., Mellis C.M., Van Asperen P.P. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child 2004, 89:928-933.
13. Tejero Garcia S., Giraldez Sanchez M.A., Cejudo P., Quintana Gallego E., Dapena J., Garcia Jimenez R., et al. Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis. Chest 2011, 140:475-481.
14. Hebestreit H., Kieser S., Rudiger S., Schenk T., Junge S., Hebestreit A., et al. Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 2006, 28:734-739.
15. Fournier C., Bosquet L., Leroy S., Perez T., Neviere R., Wallaert B. Measurement of daily physical activity in patients with cystic fibrosis. Rev Mal Respir 2005, 22:63-69.
16. Selvadurai H.C., Blimkie C.J., Meyers N., Mellis C.M., Cooper P.J., Van Asperen P.P. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002, 33:194-200.
17. Janz KFC S.I., Barr R.N., Kelly J.M. Monitoring exercise in children and adolescents with cystic fibrosis: validation of the CSA accelerometer. Cardiopulm Phys Ther J 1995, 6:3-8.
18. Beghin L., Michaud L., Loeuille G.A., Wizla-Derambure N., Sayah H., Sardet A., et al. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa. Pediatr Pulmonol 2009, 44:464-471.
19. Beghin L., Gottrand F., Michaud L., Vodougnon H., Wizla-Derambure N., Hankard R., et al. Energetic cost of physical activity in cystic fibrosis children during Pseudomonas aeruginosa pulmonary exacerbation. Clin Nutr 2005, 24:88-96.
20. Troosters T., Langer D., Vrijsen B., Segers J., Wouters K., Janssens W., et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009, 33:99-106.
21. Selvadurai H.C., Allen J., Sachinwalla T., Macauley J., Blimkie C.J., Van Asperen P.P. Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 2003, 168:1476-1480.
22. Goss C.H., Edwards T.C., Ramsey B.W., Aitken M.L., Patrick D.L. Patient-reported respiratory symptoms in cystic fibrosis. J Cyst Fibros 2009, 8:245-252.
23. Bennett A.V., Patrick D.L., Lymp J.F., Edwards T.C., Goss C.H. Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis. J Cyst Fibros 2010, 9:419-424.
24. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153:S4-S14.
25. Bassett D.R., Ainsworth B.E., Leggett S.R., Mathien C.A., Main J.A., Hunter D.C., et al. Accuracy of five electronic pedometers for measuring distance walked. Med Sci Sports Exerc 1996, 28:1071-1077.
26. Sequeira M.M., Rickenbach M., Wietlisbach V., Tullen B., Schutz Y. Physical activity assessment using a pedometer and its comparison with a questionnaire in a large population survey. Am J Epidemiol 1995, 142:989-999.
27. Vincent S.D., Pangrazi R.P., Raustorp A., Tomson L.M., Cuddihy T.F. Activity levels and body mass index of children in the United States, Sweden, and Australia. Med Sci Sports Exerc 2003, 35:1367-1373.
28. Strycker L.A., Duncan S.C., Chaumeton N.R., Duncan T.E., Toobert D.J. Reliability of pedometer data in samples of youth and older women. Int J Behav Nutr Phys Act 2007, 4:4.
29. Boucher G.P., Lands L.C., Hay J.A., Hornby L. Activity levels and the relationship to lung function and nutritional status in children with cystic fibrosis. Am J Phys Med Rehabil 1997, 76:311-315.
30. Sahlberg M.E., Svantesson U., Thomas E.M., Strandvik B. Muscular strength and function in patients with cystic fibrosis. Chest 2005, 127:1587-1592.
31. Sawicki G.S., Sellers D.E., Robinson W.M. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009, 8:91-96.
32. Nixon P.A., Orenstein D.M., Kelsey S.F. Habitual physical activity in children and adolescents with cystic fibrosis. Med Sci Sports Exerc 2001, 33:30-35.
33. Orenstein D.M., Higgins L.W. Update on the role of exercise in cystic fibrosis. Curr Opin Pulm Med 2005, 11:519-523.
34. Rowe D.A., Mahar M.I., Raedeke T.D., Lore J. Measuring physical activity in children with pedometers: reliability, reactivity, and replacement of missing data. Pediatr Exerc Sci 2004, 16:343-354.
35. Melanson E.L., Knoll J.R., Bell M.L., Donahoo W.T., Hill J.O., Nysse L.J., et al. Commercially available pedometers: considerations for accurate step counting. Prev Med 2004, 39:361-368.